Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non–Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)-Reference-Cited by-同舟云学术

Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non–Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)

Published:2018-07 Issue:7 Volume:13 Page:996-1003
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Gajra Ajeet,Zemla Tyler J.,Jatoi Aminah,Feliciano Josephine L.,Wong Melisa L.,Chen Hongbin,Maggiore Ronald,McMurray Ryan P.,Hurria Arti,Muss Hyman B.,Cohen Harvey J.,Lafky Jacqueline,Edelman Martin J.,Lilenbaum Rogerio,Le-Rademacher Jennifer G.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Endpoints for assessing drug activity in clinical trials;Pazdur;Oncologist,2008

2. Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer;Arkenau;Cancer,2011

3. Erubulin monotherapy in patients aged 70 years and older with metastatic breast cancer;Muss;Oncologist,2014

4. Effect of age on clinical outcomes in phase 1 trial participants;Mahipal;Cancer Control,2015

5. Safety and efficacy of everolimus with exemestane versus exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2;Pritchard;Clin Breast Cancer,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study;Thoracic Cancer;2024-08-28

2. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601);Journal of Geriatric Oncology;2024-07

3. The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database;Cancer Medicine;2023-10-31

4. Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials;JAMA Oncology;2023-08-01

5. Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy;Circulation Journal;2022-12-06